Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14004589 | 1.00 | KDM4E (0.34) | KDM4EMAPK8MAPK9MAPK10KMT2A | |
| SCHEMBL14004600 | 0.95 | KDM4E (0.35) | KDM4EMAPK8MAPK9MAPK10KMT2A | |
| SCHEMBL14004596 | 0.95 | KDM4E (0.35) | KDM4EMAPK8MAPK9MAPK10KMT2A | |
| SCHEMBL14626120 | 0.89 | KDM4E (0.35) | KDM4EKMT2APOLBALDH1A1MAPT | |
| SCHEMBL14626121 | 0.89 | KDM4E (0.35) | KDM4EKMT2APOLBALDH1A1MAPT | |
| SCHEMBL14004628 | 0.88 | KMT2A (0.39) | MAPK8MAPK9MAPK10KMT2AALDH1A1 | |
| SCHEMBL14004597 | 0.88 | KMT2A (0.35) | KDM4EMAPK8MAPK9MAPK10KMT2A | |
| SCHEMBL14004599 | 0.87 | PRMT1 (0.40) | KDM4EMAPK8MAPK9MAPK10KMT2A | |
| SCHEMBL14004608 | 0.87 | PRMT1 (0.40) | KDM4EMAPK8MAPK9MAPK10KMT2A | |
| SCHEMBL14004349 | 0.87 | CD40 (0.38) | KDM4EMAPK8MAPK9MAPK10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080289124-A1 | Reactive Azo Dyes, Methods for the Production Thereof and Their Use | DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080289124-A1 | Reactive Azo Dyes, Methods for the Production Thereof and Their Use | DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080289124-A1 | Reactive Azo Dyes, Methods for the Production Thereof and Their Use | IK, CYP1A1, ALKBH1 | KDM4E 390/4885MAPK8 3121/4885MAPK9 1238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.